Table 2 RASSF1A and MAL methylation frequencies in the breast carcinoma samples as determined by MS-HRM
RASSF1A Positive | RASSF1A Negative | Total | |
|---|---|---|---|
MAL Positive | 28 (38.9%) | 2 (2.8%) | 30 (41.7%) |
MAL Negative | 32 (44.4%) | 10 (13.9%) | 42 (58.3%) |
Total | 60 (83.3%) | 12 (16.7%) | 72 |